Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Billy Michael Chelliah Jebaraj

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2025
Quantification of Telomere Length in Peripheral Blood Mononuclear Cells Using Quantitative Polymerase Chain ReactionBilly Michael Chelliah Jebaraj
Blood Cancer Discovery|December 12, 2025
Overcoming BTK Inhibitor Resistance in Chronic Lymphocytic Leukemia by Targeting PKCβBilly Michael Chelliah Jebaraj, Stephan Stilgenbauer
Blood|January 1, 2026
Shifting clones: CLL evolution under pirtobrutinib treatmentBilly Michael Chelliah Jebaraj, Stephan Stilgenbauer
British Journal of Haematology|March 12, 2026
Short and complex-Telomeres and genomes in CLLBilly Michael Chelliah Jebaraj, Stephan Stilgenbauer
Frontiers in Oncology|February 1, 2021
Telomere Dysfunction in Chronic Lymphocytic LeukemiaBilly Michael Chelliah Jebaraj, Stephan Stilgenbauer
Frontiers in Oncology|May 17, 2024
Editorial: Reviews in hematologic malignancies: 2023Billy Michael Chelliah Jebaraj, Michael Liew, Felix Seyfried
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
Venetoclax: Targeting BCL2 in Hematological CancersAnnika Scheffold, Billy Michael Chelliah Jebaraj, Stephan Stilgenbauer
Leukemia & Lymphoma|October 24, 2012
BRAF mutations in chronic lymphocytic leukemiaBilly Michael Chelliah Jebaraj, Dirk Kienle, Andreas Bühler, et al.
Blood|December 18, 2012
Telomere length in mantle cell lymphomaBilly Michael Chelliah Jebaraj, Dirk Kienle, André Lechel, et al.
Blood Advances|January 20, 2023
Acquired BTK mutations associated with resistance to noncovalent BTK inhibitorsJialei Qi, Sascha Endres, Deyan Yordanov Yosifov, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2025
Quantification of Telomere Length in Peripheral Blood Mononuclear Cells Using Quantitative Polymerase Chain ReactionBilly Michael Chelliah Jebaraj
Blood Cancer Discovery|December 12, 2025
Overcoming BTK Inhibitor Resistance in Chronic Lymphocytic Leukemia by Targeting PKCβBilly Michael Chelliah Jebaraj, Stephan Stilgenbauer
Blood|January 1, 2026
Shifting clones: CLL evolution under pirtobrutinib treatmentBilly Michael Chelliah Jebaraj, Stephan Stilgenbauer
British Journal of Haematology|March 12, 2026
Short and complex-Telomeres and genomes in CLLBilly Michael Chelliah Jebaraj, Stephan Stilgenbauer
Frontiers in Oncology|February 1, 2021
Telomere Dysfunction in Chronic Lymphocytic LeukemiaBilly Michael Chelliah Jebaraj, Stephan Stilgenbauer
Frontiers in Oncology|May 17, 2024
Editorial: Reviews in hematologic malignancies: 2023Billy Michael Chelliah Jebaraj, Michael Liew, Felix Seyfried
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
Venetoclax: Targeting BCL2 in Hematological CancersAnnika Scheffold, Billy Michael Chelliah Jebaraj, Stephan Stilgenbauer
Leukemia & Lymphoma|October 24, 2012
BRAF mutations in chronic lymphocytic leukemiaBilly Michael Chelliah Jebaraj, Dirk Kienle, Andreas Bühler, et al.
Blood|December 18, 2012
Telomere length in mantle cell lymphomaBilly Michael Chelliah Jebaraj, Dirk Kienle, André Lechel, et al.
Blood Advances|January 20, 2023
Acquired BTK mutations associated with resistance to noncovalent BTK inhibitorsJialei Qi, Sascha Endres, Deyan Yordanov Yosifov, et al.
Pageof 3